News & Media

|News & Media
News & Media 2017-06-30T20:03:10+00:00
2ndAug, 2017

Press Release: Firma provides support associated with FDA approval of Baxdela™

August 2nd, 2017|Tags: |

Firma Clinical Research, an ISO quality management-certified clinical research organization (CRO), is pleased to announce its contribution to the FDA approval of Melinta Therapeutics’ lead antibiotic, Baxdela™ (delafloxacin), for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible bacteria.